Your browser doesn't support javascript.
loading
Outcomes of axitinib versus sunitinib as first-line therapy to patients with metastatic renal cell carcinoma in the immune-oncology era.
Numakura, Kazuyuki; Muto, Yumin; Naito, Sei; Hatakeyama, Shingo; Kato, Renpei; Koguchi, Tomoyuki; Kojima, Takahiro; Kawasaki, Yoshihide; Kandori, Syuya; Kawamura, Sadafumi; Arai, Yoichi; Ito, Akihiro; Nishiyama, Hiroyuki; Kojima, Yoshiyuki; Obara, Wataru; Ohyama, Chikara; Tsuchiya, Norihiko; Habuchi, Tomonori.
Afiliación
  • Numakura K; Department of Urology, Akita University Graduate School of Medicine, Akita, Japan.
  • Muto Y; Department of Urology, Akita University Graduate School of Medicine, Akita, Japan.
  • Naito S; Department of Urology, Yamagata University Faculty of Medicine, Yamagata, Japan.
  • Hatakeyama S; Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Kato R; Department of Urology, Iwate Medical University, Morioka, Japan.
  • Koguchi T; Department of Urology, Fukushima Medical University, Fukushima, Japan.
  • Kojima T; Department of Urology and Andrology, Tsukuba University Graduate School of Comprehensive Human Sciences, Tsukuba, Japan.
  • Kawasaki Y; Department of Urology, Tohoku University Graduate School of Medicine, Tohoku, Japan.
  • Kandori S; Department of Urology and Andrology, Tsukuba University Graduate School of Comprehensive Human Sciences, Tsukuba, Japan.
  • Kawamura S; Department of Urology, Miyagi Cancer Center, Natori, Japan.
  • Arai Y; Department of Urology, Miyagi Cancer Center, Natori, Japan.
  • Ito A; Department of Urology, Tohoku University Graduate School of Medicine, Tohoku, Japan.
  • Nishiyama H; Department of Urology and Andrology, Tsukuba University Graduate School of Comprehensive Human Sciences, Tsukuba, Japan.
  • Kojima Y; Department of Urology, Fukushima Medical University, Fukushima, Japan.
  • Obara W; Department of Urology, Iwate Medical University, Morioka, Japan.
  • Ohyama C; Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Tsuchiya N; Department of Urology, Yamagata University Faculty of Medicine, Yamagata, Japan.
  • Habuchi T; Department of Urology, Akita University Graduate School of Medicine, Akita, Japan.
Cancer Med ; 10(17): 5839-5846, 2021 09.
Article en En | MEDLINE | ID: mdl-34313025
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Protocolos de Quimioterapia Combinada Antineoplásica / Sunitinib / Axitinib / Neoplasias Renales Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Año: 2021 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Protocolos de Quimioterapia Combinada Antineoplásica / Sunitinib / Axitinib / Neoplasias Renales Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Año: 2021 Tipo del documento: Article País de afiliación: Japón